Teodora Komazec

Teodora Komazec completed her undergraduate studies at the Faculty of Biology, University of Belgrade on the module "Molecular Biology and Physiology" in 2019. At the same faculty, in 2020 she completed her Master's studies in the module "Immunobiology" under the title "Examination of the antiproliferative potential of selected pyridone derivatives on HCT-116 and MDA-MB-231 cell lines", and in 2021 she enrolled in doctoral studies on the module "Cellular and molecular oncology". Since April 2022, she has been employed in the Department of Immunology at the Institute for Biological Research "Siniša Stanković" – National Institute of the Republic of Serbia.

Teodora is part of the project team of the PRISMA (ADVANCED) program funded by the Science Fund of the Republic of Serbia, as well as the bilateral cooperation project with the German Academic Exchange Service (DAAD).

She is a member of several national and international societies including: the Serbian Society of Cancer Researchers (SDIR), the European Association for Cancer Research (EARC), the Serbian Society for Molecular Biology (MolBioS), the Club of Serbian Young Immunologists (KMIS), Young European Federation of Immunologists of societies (yEFIS), Serbian Biochemical Society (BDS), Federation of European Biochemical Societies (FEBS) and Serbian Society for Immunology, Molecular Oncology and Regenerative Medicine (SDIOR).

Her research interests are: tumor biology, experimental oncology, testing the antitumor activity of newly synthesized compounds in vitro and in vivo, tumor immunology, monitoring the response of tumors and the tumor microenvironment to the application of potential therapeutics, research on the molecular mechanisms and signaling pathways involved in cancer regulation.